Status:
COMPLETED
Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACU-4429 in Subjects With Geographic Atrophy
Lead Sponsor:
Kubota Vision Inc.
Collaborating Sponsors:
Otsuka Pharmaceutical Co., Ltd.
Conditions:
Dry Age-related Macular Degeneration
Geographic Atrophy
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of the investigational drug ACU-4429 in subjects with geographic atrophy.
Eligibility Criteria
Inclusion
- Have a clinical diagnosis of geographic atrophy, as defined in the protocol
Exclusion
- Currently receiving or has received a medication prohibited by the protocol
Key Trial Info
Start Date :
October 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT01002950
Start Date
October 1 2009
End Date
October 1 2012
Last Update
March 11 2014
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Retinal Consultants of Arizona
Phoenix, Arizona, United States, 85014
2
Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States, 90211
3
Covance Clinical Research Unit, Inc.
Daytona Beach, Florida, United States, 32117
4
National Ophthalmic Research Institute
Fort Meyers, Florida, United States, 33912